Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Ocular Distribution and Pharmacodynamics of SF0166, a Topically Administered alphavbeta3 Integrin Antagonist, for the Treatment of Retinal Diseases.

Askew,B.C., Furuya,T., and Edwards,D.S. 2018. Ocular Distribution and Pharmacodynamics of SF0166, a Topically Administered alphavbeta3 Integrin Antagonist, for the Treatment of Retinal Diseases. J. Pharmacol. Exp. Ther. 366, 244-250.